Cytoville, Inc. announced that it has entered into a series A preferred stock purchase agreement with certain investors in March 2015. The company will issue series A preferred shares.

On the same day the company issued 7,350,000 shares at $0.50 per share for gross proceeds of $3,675,000 in first tranche.